Company Overview

Body and Mind Inc. is a publicly traded cannabis company operating in the regulated cannabis industry in the United States and Canada. The company focuses on the cultivation, processing, manufacturing, and retail sale of cannabis products, including flower, concentrates, edibles, and wellness-oriented cannabis derivatives. Body and Mind operates through a vertically integrated model in several jurisdictions, combining production assets with dispensary operations and branded product distribution. Its primary revenue drivers include wholesale cannabis product sales and retail dispensary sales through licensed operations and affiliated entities.

The company was founded in 2010 and evolved from an early-stage cannabis investment and licensing business into a multi-state operator with exposure to cultivation, processing, and retail activities. Body and Mind has emphasized smaller but strategically selected markets where licensing structures and limited competition may provide operational advantages. The company has pursued a capital-light expansion strategy in certain jurisdictions through partnerships, management agreements, and local operating structures. Public disclosures, including SEC filings and Canadian securities filings, indicate the company has focused on disciplined market entry rather than rapid national scale compared with larger cannabis operators.

Business Operations

Body and Mind conducts operations through several cannabis-related business units, including cultivation facilities, production operations, branded product manufacturing, and dispensary retail assets. Its operating footprint has included activities in states such as Nevada, California, Ohio, Illinois, and Arkansas, although operational scope has shifted over time based on licensing, restructuring, and market conditions. The company generates revenue primarily from retail cannabis sales, wholesale distribution, and branded products sold through licensed dispensaries and partner channels.

The company has controlled or participated in operations tied to cultivation technology, extraction capabilities, and cannabis product manufacturing. Key business entities and affiliated operations have included NMG OH 1, LLC, DEP Nevada, Inc., and retail dispensary interests associated with state-specific licenses. Body and Mind has also entered strategic partnerships with local operators to satisfy state-level ownership and compliance requirements in regulated cannabis markets. Public company filings indicate that operational structures can vary by jurisdiction due to differing cannabis regulations and licensing frameworks.

Strategic Position & Investments

Body and Mind’s strategic direction has centered on targeted expansion in limited-license cannabis markets while maintaining operational flexibility and capital discipline. The company has historically pursued acquisitions, licensing agreements, and joint operating arrangements to establish market presence without undertaking the scale of investment associated with large cultivation expansions. Management has emphasized branded cannabis products and vertically integrated operations intended to improve margins and customer retention.

The company has made investments in dispensary operations, cultivation facilities, and manufacturing infrastructure across multiple U.S. jurisdictions. Acquisitions and investments have included interests tied to cannabis licenses and operating entities in states with regulated medical or adult-use cannabis frameworks. Body and Mind has also explored emerging product categories such as cannabis concentrates, infused products, and wellness-oriented cannabis offerings. Public disclosures suggest the company continues to evaluate strategic opportunities in developing cannabis markets, though some expansion initiatives have depended on regulatory approvals and financing availability.

Geographic Footprint

Body and Mind is headquartered in Vancouver, Canada, and has maintained operational exposure primarily within the United States cannabis market. Its activities have historically focused on regulated cannabis jurisdictions including Nevada, California, Ohio, Arkansas, and Illinois. The company’s market presence has varied over time due to licensing changes, operational restructuring, and strategic reallocations of capital.

The company’s influence outside North America appears limited based on publicly available filings and disclosures. Its operational emphasis has remained concentrated on U.S. state-regulated cannabis markets rather than international cannabis exports or multinational pharmaceutical distribution. Public records indicate that Body and Mind’s strategy has favored selective participation in regional markets where management believes licensing constraints and local partnerships can support long-term positioning.

Leadership & Governance

Body and Mind’s leadership team has included executives with backgrounds in cannabis operations, finance, capital markets, and regulated industries. The company’s governance structure follows public-company reporting standards through filings with U.S. and Canadian securities regulators. Management commentary in public filings has emphasized operational efficiency, disciplined capital allocation, and regulatory compliance within evolving cannabis markets.

Key executives and leadership figures have included:

• Michael Mills – Chief Executive Officer
• Trip Hoffman – Chief Financial Officer
• Lucas McCann – Chief Revenue Officer
• Robert Hasman – Director
• Seun Adedeji – Director

Public filings and investor materials indicate that leadership has prioritized sustainable market participation and strategic partnerships rather than rapid expansion through large-scale debt financing. Certain executive roles and board positions may have changed over time, and investors are advised to consult the most recent SEC filings and Canadian regulatory disclosures for current governance details.